Skip to main content
SpringerLink
Log in

Neuromuskuläre Erkrankungen bei Intensivpatienten

  • Chapter
  • First Online:
Die Intensivmedizin

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 389.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Alkaabi JM, Mushtaq A, Al-Maskari FN, Moussa NA, Gariballa S (2010) Hypokalemic periodic paralysis: a case series, review of the literature and update of management. Eur J Emerg Med 17:45–47

    Article  PubMed  Google Scholar 

  • Allenbach Y, Benveniste O (2013) Acquired necrotizing myopathies. Curr Opin Neurol 26:554–560

    Article  CAS  PubMed  Google Scholar 

  • Anderson K, Bloomer J, Bonkovsky H, Kushner J, Pierach C, Pimstone N, Desnick R (2005) Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 142:439–450

    Article  PubMed  Google Scholar 

  • Arnon S, Schechter R, Maslanka S, Jewell N, Hatheway C (2006) Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 354:462–471

    Article  CAS  PubMed  Google Scholar 

  • Benatar M, Kaminski H (2006) Medical and surgical treatment for ocular myasthenia. Cochrane Database Syst Rev CD005081

    Google Scholar 

  • Bloch S, Polkey MI, Griffiths M, Kemp P (2012) Molecular mechanisms of intensive care unit‐acquired weakness. Eur Respir J 39:1000–1011

    Article  CAS  PubMed  Google Scholar 

  • Bolton C (2005) Neuromuscular manifestations of critical illness. Muscle Nerve 32:140–163

    Article  PubMed  Google Scholar 

  • Buttmann M, Kaveri S, Hartung HP (2013) Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders. Trends Pharmacol Sci 34:445–457

    Article  CAS  PubMed  Google Scholar 

  • Carstens PO, Schmidt J (2014) Diagnosis, pathogenesis and treatment of myositis: recent advances. Clin Exp Immunol 175:425–438

    Article  Google Scholar 

  • Cavalcante P, Bernasconi P, Mantegazza R (2012) Autoimmune mechanisms in myasthenia gravis. Curr Opin Neurol 25:621–629

    Article  CAS  PubMed  Google Scholar 

  • Chalela JA (2001) Pearls and pitfalls in the intensive care management of Guillain‐Barre syndrome. Semin Neurol 21:399–405

    Article  CAS  PubMed  Google Scholar 

  • Chavada G, Willison HJ (2012) Autoantibodies in immune‐mediated neuropathies. Curr Opin Neurol 25:550–555

    Article  CAS  PubMed  Google Scholar 

  • Chawla J, Gruener G (2010) Management of critical illness polyneuropathy and myopathy. Neurol Clin 28:961–977

    Article  PubMed  Google Scholar 

  • Cherington M (2004) Botulism: update and review. Semin Neurol 24:155–163

    Article  PubMed  Google Scholar 

  • Dalakas MC (2013) Pathophysiology of autoimmune polyneuropathies. Presse Med 42:e181–e192

    Article  PubMed  Google Scholar 

  • de Letter M, Schmitz P, Visser L, Verheul F, Schellens R, de Op Coul D, van der Meché F (2001) Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29:2281–2286

    Article  PubMed  Google Scholar 

  • Deymeer F, Gungor-Tuncer O, Yilmaz V, Parman Y, Serdaroglu P, Ozdemir C, Vincent A, Saruhan-Direskeneli G (2007) Clinical comparison of anti‐MuSK‐ vs anti‐AChR‐positive and seronegative myasthenia gravis. Neurology 68:609–611

    Article  CAS  PubMed  Google Scholar 

  • Dillon F (2004) Anesthesia issues in the perioperative management of myasthenia gravis. Semin Neurol 24:83–94

    Article  PubMed  Google Scholar 

  • Dimachkie MM, Barohn RJ (2013) Guillain‐barré syndrome. Curr Treat Options Neurol 15:338–349

    Article  PubMed  Google Scholar 

  • Díaz-Manera J, Rojas García R, Illa I (2012) Treatment strategies for myasthenia gravis: an update. Expert Opin Pharmacother 13:1873–1883

    Article  PubMed  Google Scholar 

  • Eikermann M, Koch G, Gerwig M, Ochterbeck C, Beiderlinden M, Koeppen S, Neuhäuser M, Peters J (2006) Muscle force and fatigue in patients with sepsis and multiorgan failure. Intensive Care Med 32:251–259

    Article  CAS  PubMed  Google Scholar 

  • Engel W, Askanas V (2006) Inclusion‐body myositis: clinical, diagnostic, and pathologic aspects. Neurology 66:S20–S29

    Article  PubMed  Google Scholar 

  • Engstrom J (2004) Myasthenia gravis: diagnostic mimics. Semin Neurol 24:141–147

    Article  PubMed  Google Scholar 

  • Fontaine B, Fournier E, Sternberg D, Vicart S, Tabti N (2007) Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder. Neurotherapeutics 4:225–232

    Article  CAS  PubMed  Google Scholar 

  • Gajdos P, Chevret S, Toyka KV (2012) Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev 12:CD002277

    PubMed  Google Scholar 

  • Gilchrist J (2002) Overview of neuromuscular disorders affecting respiratory function. Semin Respir Crit Care Med 23:191–200

    Article  PubMed  Google Scholar 

  • Gilhus NE, Owe JF, Hoff JM, Romi F, Skeie GO, Aarli JA (2011) Myasthenia gravis: a review of available treatment approaches. Autoimmune Dis 847393

    Google Scholar 

  • Gilhus NE (2012) Myasthenia and the neuromuscular junction. Curr Opin Neurol 25:523–529

    Article  CAS  PubMed  Google Scholar 

  • Goodman B, Boon A (2008) Critical illness neuromyopathy. Phys Med Rehabil Clin N Am 19:97–110 (vii)

    Article  PubMed  Google Scholar 

  • Green D (2005) Weakness in the ICU: Guillain‐Barré syndrome, myasthenia gravis, and critical illness polyneuropathy/myopathy. Neurologist 11:338–347

    Article  PubMed  Google Scholar 

  • Guptill JT, Oakley D, Kuchibhatla M, Guidon AC, Hobson-Webb LD, Massey JM, Sanders DB, Juel VC (2013) A retrospective study of complications of therapeutic plasma exchange in myasthenia. Muscle Nerve 47:170–176

    Article  PubMed  Google Scholar 

  • Gutmann L, Blumenthal D, Schochet S (1996) Acute type II myofiber atrophy in critical illness. Neurology 46:819–821

    Article  CAS  PubMed  Google Scholar 

  • Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV (2001) Preceding infections, immune factors, and outcome in Guillain‐Barre syndrome. Neurology 56:758–765

    Article  CAS  PubMed  Google Scholar 

  • Hain B, Jordan K, Deschauer M, Zierz S (2006) Successful treatment of MuSK antibody‐positive myasthenia gravis with rituximab. Muscle Nerve 33:575–580

    Article  PubMed  Google Scholar 

  • Hartung HP, Keller-Stanislawski B, Hughes RA, Lehmann HC (2012) Guillain‐Barré syndrome after exposure to influenza. Nervenarzt 83:714–730

    Article  PubMed  Google Scholar 

  • Henderson R, Sandroni P, Wijdicks E (2005) Chronic inflammatory demyelinating polyneuropathy and respiratory failure. J Neurol 252:1235–1237

    Article  PubMed  Google Scholar 

  • Howard RS, Tan SV, Z’Graggen WJ (2008) Weakness on the intensive care unit. Pract Neurol 8:280–295

    Article  CAS  PubMed  Google Scholar 

  • Hsieh M, Lyu R, Chang W, Chang K, Chen C, Chang H, Wu Y, Chen S, Ro L (2008) Hypokalemic thyrotoxic periodic paralysis: clinical characteristics and predictors of recurrent paralytic attacks. Eur J Neurol 15:559–564

    Article  PubMed  Google Scholar 

  • Hughes RA, Cornblath DR (2005) Guillain‐Barre syndrome. Lancet 366:1653–1666

    Article  CAS  PubMed  Google Scholar 

  • Hughes R, Donofrio P, Bril V, Dalakas M, Deng C, Hanna K, Hartung H, Latov N, Merkies I, van Doorn P (2008) Intravenous immune globulin (10 % caprylate‐chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo‐controlled trial. Lancet Neurol 7:136–144

    Article  CAS  PubMed  Google Scholar 

  • Hughes RA, Swan AV, van Doorn PA (2012) Intravenous immunoglobulin for Guillain‐Barré syndrome. Cochrane Database Syst Rev 7:CD002063

    PubMed  Google Scholar 

  • Hughes RA, van Doorn PA (2012) Corticosteroids for Guillain‐Barré syndrome. Cochrane Database Syst Rev 8:CD001446

    PubMed  Google Scholar 

  • Hughes RA, Pritchard J, Hadden RD (2013) Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain‐Barré syndrome. Cochrane Database Syst Rev 2:CD008630

    PubMed  Google Scholar 

  • Hund EF, Borel CO, Cornblath DR, Hanley DF, McKhann GM (1993) Intensive management and treatment of severe Guillain‐Barre syndrome. Crit Care Med 21:433–446

    Article  CAS  PubMed  Google Scholar 

  • Hund E (2001) Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 248:929–934

    Article  CAS  PubMed  Google Scholar 

  • Jander S, Hartung HP (2006) Aktuelle Aspekte in der Pathogenese, Diagnostik und Therapie der Myasthenia gravis. Akt Neurol 32:3–9

    Article  Google Scholar 

  • Judemann K, Lunz D, Zausig YA, Graf BM, Zink W (2011) Intensive care unit‐acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy. Anaesthesist 60:887–901

    Article  CAS  PubMed  Google Scholar 

  • Keogh M, Sedehizadeh S, Maddison P (2011) Treatment for Lambert‐Eaton myasthenic syndrome. Cochrane Database Syst Rev CD003279

    Google Scholar 

  • Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP (2004) Advances in understanding and treatment of immune‐mediated disorders of the peripheral nervous system. Muscle Nerve 30:131–156

    Article  CAS  PubMed  Google Scholar 

  • Kieseier B, Meyer Zu Hörste G, Lehmann H, Gold R, Hartung H (2008) Intravenous immunoglobulins in the treatment of immune neuropathies. Curr Opin Neurol 21:555–562

    Article  CAS  PubMed  Google Scholar 

  • Kieseier BC, Lehmann HC, Meyer Zu Hörste G (2012) Autoimmune diseases of the peripheral nervous system. Autoimmun Rev 11:191–195

    Article  CAS  PubMed  Google Scholar 

  • Koller H, Kieseier BC, Jander S, Hartung HP (2005) Chronic inflammatory demyelinating neuropathy. N Engl J Med 352:1343–1356

    Article  PubMed  Google Scholar 

  • Koneczny I, Cossins J, Vincent A (2014) The role of muscle‐specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis. J Anat 224:29–35

    Article  CAS  PubMed  Google Scholar 

  • Kress JP, Hall JB (2014) ICU‐acquired weakness and recovery from critical illness. N Engl J Med 370:1626–1635

    Article  CAS  PubMed  Google Scholar 

  • Kung A (2006) Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab 91:2490–2495

    Article  CAS  PubMed  Google Scholar 

  • Kuwabara S, Yuki N (2013) Axonal Guillain‐Barré syndrome: concepts and controversies. Lancet Neurol 12:1180–1188

    Article  PubMed  Google Scholar 

  • Latronico N, Rasulo FA (2010) Presentation and management of ICU myopathy and neuropathy. Curr Opin Crit Care 16:123–127

    Article  PubMed  Google Scholar 

  • Latronico N, Tomelleri G, Filosto M (2012) Critical illness myopathy. Curr Opin Rheumatol 24:616–622

    Article  CAS  PubMed  Google Scholar 

  • Lazarou IN, Guerne PA (2013) Classification, diagnosis and management of idiopathic inflammatory myopathies. J Rheumatol 40:550–564

    Article  CAS  PubMed  Google Scholar 

  • Lefaucheur J, Nordine T, Rodriguez P, Brochard L (2006) Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry 77:500–506

    Article  PubMed Central  PubMed  Google Scholar 

  • Lehmann HC, Hartung HP, Hetzel GR, Kieseier BC (2007aa) Plasma exchange as a therapeutic option in neurological disorders. Nervenarzt 78:168–170 (166, 172–166)

    Article  Google Scholar 

  • Lehmann HC, Kohne A, zu Horste GM, Kieseier BC (2007bb) Incidence of Guillain‐Barre syndrome in Germany. J Peripher Nerv Syst 12:285

    Article  PubMed  Google Scholar 

  • Lehmann H, Hartung H (2008) Complementing the therapeutic armamentarium for Miller Fisher Syndrome and related immune neuropathies. Brain 131:1168–1170

    Article  PubMed  Google Scholar 

  • Lehmann HC, Meyer zu Hörste G, Hartung HP (2009) Pathogenesis and treatment of immune‐mediated neuropathies. Ther Adv Neurol Dis 2:261–281

    Article  Google Scholar 

  • Lehmann HC, Hughes RA, Kieseier BC, Hartung H-P (2012) Recent developments and future directions in Guillain‐Barré syndrome. Journal Peripheral Nervous System (in press)

    Google Scholar 

  • Lynn D, Woda R, Mendell J (1994) Respiratory dysfunction in muscular dystrophy and other myopathies. Clin Chest Med 15:661–674

    CAS  PubMed  Google Scholar 

  • Maciel RM, Lindsey SC, da Dias Silva MR (2011) Novel etiopathophysiological aspects of thyrotoxic periodic paralysis. Nat Rev Endocrinol 7:657–667

    Article  CAS  PubMed  Google Scholar 

  • Maddison P, Newsom-Davis J (2003) Treatment for Lambert‐Eaton myasthenic syndrome. Cochrane Database Syst Rev CD003279

    Google Scholar 

  • Marinelli WA, Leatherman JW (2002) Neuromuscular disorders in the intensive care unit. Crit Care Clin 18:915–929

    Article  PubMed  Google Scholar 

  • Mehndiratta MM, Pandey S, Kuntzer T (2011) Acetylcholinesterase inhibitor treatment for myasthenia gravis. Cochrane Database Syst Rev CD006986

    Google Scholar 

  • Meyer zu Horste G, Hartung HP, Kieseier BC (2007) From bench to bedside‐‐experimental rationale for immune‐specific therapies in the inflamed peripheral nerve. Nat Clin Pract Neurol 3:198–211

    Article  PubMed  Google Scholar 

  • Mukerji S, Aloka F, Farooq M, Kassab M, Abela G (2009) Cardiovascular complications of the Guillain‐Barré syndrome. Am J Cardiol 104:1452–1455

    Article  PubMed  Google Scholar 

  • Müllges W, Toyka KV, Hartung H (1994) Acute muscular weakness. In: Hacke W, Hanley DF (Hrsg) Neurocritical Care. Berlin, S 307–320

    Google Scholar 

  • Palmer K (2006) Abdominal pain due to acute intermittent porphyria: when is the sound of hoof‐beats not horses, but zebras? A case report. Dimens Crit Care Nurs 25:103–109

    Article  PubMed  Google Scholar 

  • Pati S, Goodfellow J, Iyadurai S, Hilton-Jones D (2008) Approach to critical illness polyneuropathy and myopathy. Postgrad Med J 84:354–360

    Article  CAS  PubMed  Google Scholar 

  • Patwa HS, Chaudhry V, Katzberg H, Rae-Grant AD, So YT (2012) Evidence‐based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 78:1009–1015

    Article  CAS  PubMed  Google Scholar 

  • Press R, Mata S, Lolli F, Zhu J, Andersson T, Link H (2001) Temporal profile of anti‐ganglioside antibodies and their relation to clinical parameters and treatment in Guillain‐Barre syndrome. J Neurol Sci 190:41–47

    Article  CAS  PubMed  Google Scholar 

  • Rabinstein A (2005) Update on respiratory management of critically ill neurologic patients. Curr Neurol Neurosci Rep 5:476–482

    Article  PubMed  Google Scholar 

  • Raja Rayan DL, Hanna MG (2010) Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. Curr Opin Neurol 23:466–476

    Article  CAS  PubMed  Google Scholar 

  • Rajabally YA, Uncini A (2012) Outcome and its predictors in Guillain‐Barre syndrome. J Neurol Neurosurg Psychiatry 83:711–718

    Article  PubMed  Google Scholar 

  • Raju R, Dalakas M (2005) Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain 128:1887–1896

    Article  PubMed  Google Scholar 

  • Raphaël JC, Chevret S, Hughes RA, Annane D (2012) Plasma exchange for Guillain‐Barré syndrome. Cochrane Database Syst Rev 7:CD001798

    PubMed  Google Scholar 

  • Rezania K, Goldenberg FD, White S (2012) Neuromuscular disorders and acute respiratory failure: diagnosis and management. Neurol Clin 30:161–185 (viii)

    Article  PubMed  Google Scholar 

  • Saperstein D, Barohn R (2004) Management of myasthenia gravis. Semin Neurol 24:41–48

    Article  PubMed  Google Scholar 

  • Schneider-Gold C, Hartung H, Gold R (2006) Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases. Muscle Nerve 34:284–291

    Article  CAS  PubMed  Google Scholar 

  • Sederholm BH (2010) Treatment of acute immune‐mediated neuropathies: Guillain‐Barré syndrome and clinical variants. Semin Neurol 30:365–372

    Article  PubMed  Google Scholar 

  • Sejvar JJ, Baughman AL, Wise M, Morgan OW (2011) Population incidence of guillain‐barré syndrome: a systematic review and meta‐analysis. Neuroepidemiology 36:123–133

    Article  PubMed  Google Scholar 

  • Shahrizaila N, Yuki N (2013) Bickerstaff brainstem encephalitis and Fisher syndrome: anti‐GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry 84:576–583

    Article  PubMed  Google Scholar 

  • Spillane J, Higham E, Kullmann DM (2012) Myasthenia gravis. BMJ 345:8497

    Article  Google Scholar 

  • Spillane J, Hirsch NP, Kullmann DM, Taylor C, Howard RS (2014) Myasthenia gravis ‐ treatment of acute severe exacerbations in the intensive care unit results in a favourable long‐term prognosis. Eur J Neurol 21:171–173

    Article  CAS  PubMed  Google Scholar 

  • Stangel M, Hartung H, Gold R, Kieseier B (2009) The significance of intravenous immunoglobulin in treatment of immune‐mediated polyneuropathies. Nervenarzt 80:678–687

    Article  CAS  PubMed  Google Scholar 

  • Thomas C, Mayer S, Gungor Y, Swarup R, Webster E, Chang I, Brannagan T, Fink M, Rowland L (1997) Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology 48:1253–1260

    Article  CAS  PubMed  Google Scholar 

  • van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC (2013) Mortality in Guillain‐Barre syndrome. Neurology 80:1650–1654

    Article  PubMed  Google Scholar 

  • van Doorn PA, Ruts L, Jacobs BC (2008) Clinical features, pathogenesis, and treatment of Guillain‐Barre syndrome. Lancet Neurol 7:939–950

    Article  PubMed  Google Scholar 

  • Wijdicks E, Henderson R, McClelland R (2003) Emergency intubation for respiratory failure in Guillain‐Barré syndrome. Arch Neurol 60:947–948

    Article  PubMed  Google Scholar 

  • Winer JB (2011) Guillain‐Barré syndrome: clinical variants and their pathogenesis. J Neuroimmunol 231:70–72

    Article  CAS  PubMed  Google Scholar 

  • Yeh J, Chen W, Chiu H (2003) Predicting the course of myasthenic weakness following double filtration plasmapheresis. Acta Neurol Scand 108:174–178

    Article  CAS  PubMed  Google Scholar 

  • Yuki N, Hartung HP (2012) Guillain‐Barré syndrome. N Engl J Med 366:2294–2304

    Article  CAS  PubMed  Google Scholar 

  • Yuki N, Odaka M (2005) Ganglioside mimicry as a cause of Guillain‐Barre syndrome. Curr Opin Neurol 18:557–561

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Klinik, Universitätsklinikum Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Deutschland

    Prof. Dr. Hans-Peter Hartung & Dr. med. Helmar C. Lehmann

  2. Neurologische Universitätsklinik, Universitätsklinikum Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Deutschland

    Bernd C. Kieseier Prof. Dr.

Authors
  1. Prof. Dr. Hans-Peter Hartung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. med. Helmar C. Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernd C. Kieseier Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Anästhesiologie, RWTH Aachen Universitätsklinikum Aachen, Aachen, Germany

    Gernot Marx

  2. Klinik für Chirurgie, Universitätsklinikum Schleswig-Holstein Campus Lübeck, Lübeck, Germany

    Elke Muhl

  3. Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Goethe-Universität Frankfurt, Frankfurt, Hessen, Germany

    Kai Zacharowski

  4. Medizinische Klinik I, Universitätsklinikum Frankfurt, Frankfurt, Germany

    Stefan Zeuzem

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hartung, HP., Lehmann, H.C., Kieseier, B.C. (2015). Neuromuskuläre Erkrankungen bei Intensivpatienten. In: Marx, G., Muhl, E., Zacharowski, K., Zeuzem, S. (eds) Die Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54953-3_48

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54953-3_48

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54952-6

  • Online ISBN: 978-3-642-54953-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation